Clinical trial
A Randomized Controlled Trial of LED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological Myopia
NCT07312214 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of LED Red Light in Modulating Choroidal Microcirculation to Retard Retinal Atrophy in Pathological Myopia
- Lead sponsor
- Shanghai Eye Disease Prevention and Treatment Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 31, 2025
- Completion date
- December 30, 2028
- Enrollment
- 158 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pathologic myopia